Unicycive Therapeautics, Inc.
Unicycive’s Doug Jermasek, EVP-Corporate Development Discusses the Importance of Medication Compliance and the Issues with Pill Burden
Language: | English |
Company: | Unicycive Therapeautics, Inc. |
United States | |
ISIN: | US90466Y1038 |
EQS News ID: | 1482189 |
End of News | EQS News Service |
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden